Serena Deiana - Publications

Affiliations: 
Boehringer Ingelheim 
Area:
Neuroscience

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Ponserre M, Ionescu TM, Franz AA, Deiana S, Schuelert N, Lamla T, Williams RH, Wotjak CT, Hobson S, Dine J, Omrani A. Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction. Neuropharmacology. 109970. PMID 38685343 DOI: 10.1016/j.neuropharm.2024.109970  0.34
2022 Latuske P, von Heimendahl M, Deiana S, Wotjak CT, du Hoffmann J. Sustained MK-801 induced deficit in a novel probabilistic reversal learning task. Frontiers in Pharmacology. 13: 898548. PMID 36313373 DOI: 10.3389/fphar.2022.898548  0.316
2022 Deiana S, Hauber W, Munster A, Sommer S, Ferger B, Marti A, Schmid B, Dorner-Ciossek C, Rosenbrock H. Pro-cognitive effects of the GlyT1 inhibitor Bitopertin in rodents. European Journal of Pharmacology. 175306. PMID 36183855 DOI: 10.1016/j.ejphar.2022.175306  0.429
2015 Deiana S, Watanabe A, Yamasaki Y, Amada N, Kikuchi T, Stott C, Riedel G. MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol. Behavioural Pharmacology. 26: 748-65. PMID 26287433 DOI: 10.1097/Fbp.0000000000000178  0.304
2009 Deiana S, Harrington CR, Wischik CM, Riedel G. Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. Psychopharmacology. 202: 53-65. PMID 19005644 DOI: 10.1007/S00213-008-1394-2  0.309
Show low-probability matches.